$2.72 Billion is the total value of Eventide Asset Management's 145 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 17.4% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ASND | Buy | ASCENDIS PHARMA A Ssponsored adr | $109,472,000 | +18.7% | 1,544,900 | +11.4% | 4.02% | +5.0% |
SRPT | Buy | SAREPTA THERAPEUTICS INC | $100,136,000 | +102.0% | 620,000 | +65.3% | 3.68% | +78.8% |
XPO | XPO LOGISTICS INC | $89,966,000 | +14.0% | 788,000 | 0.0% | 3.30% | +0.9% | |
SEND | New | SENDGRID INC | $72,427,000 | – | 1,968,653 | +100.0% | 2.66% | – |
SAGE | Buy | SAGE THERAPEUTICS INC | $69,778,000 | +20.5% | 494,000 | +33.5% | 2.56% | +6.6% |
LOW | LOWES COS INC | $64,873,000 | +20.1% | 565,000 | 0.0% | 2.38% | +6.3% | |
VRTX | Buy | VERTEX PHARMACEUTICALS INC | $60,328,000 | +46.1% | 313,000 | +28.8% | 2.22% | +29.3% |
W | Sell | WAYFAIR INCcl a | $59,068,000 | -20.5% | 400,000 | -36.1% | 2.17% | -29.7% |
ZGNX | Buy | ZOGENIX INC | $58,716,000 | +177.9% | 1,183,792 | +147.7% | 2.16% | +145.8% |
MYOV | Buy | MYOVANT SCIENCES LTD | $56,153,000 | +53.3% | 2,115,000 | +32.1% | 2.06% | +35.7% |
SPLK | SPLUNK INC | $54,772,000 | +22.0% | 453,000 | 0.0% | 2.01% | +7.9% | |
TTD | THE TRADE DESK INC | $54,328,000 | +60.9% | 360,000 | 0.0% | 2.00% | +42.4% | |
VRNS | Buy | VARONIS SYS INC | $53,399,000 | +40.7% | 729,000 | +43.1% | 1.96% | +24.5% |
HUBS | HUBSPOT INC | $52,833,000 | +20.4% | 350,000 | 0.0% | 1.94% | +6.5% | |
AIMT | Buy | AIMMUNE THERAPEUTICS INC | $47,440,000 | +8.9% | 1,739,000 | +7.3% | 1.74% | -3.7% |
MIC | Sell | MACQUARIE INFRASTRUCTURE COR | $47,422,000 | +8.9% | 1,028,000 | -0.4% | 1.74% | -3.6% |
PANW | PALO ALTO NETWORKS INC | $46,854,000 | +9.6% | 208,000 | 0.0% | 1.72% | -3.0% | |
AVRO | AVROBIO INC | $46,421,000 | +81.6% | 928,891 | 0.0% | 1.70% | +60.7% | |
ALTR | New | ALTAIR ENGR INC | $43,450,000 | – | 1,000,000 | +100.0% | 1.60% | – |
WCN | WASTE CONNECTIONS INC | $41,241,000 | +6.0% | 517,000 | 0.0% | 1.52% | -6.2% | |
BLUE | BLUEBIRD BIO INC | $40,530,000 | -7.0% | 277,603 | 0.0% | 1.49% | -17.7% | |
LOXO | LOXO ONCOLOGY INC | $39,120,000 | -1.5% | 229,000 | 0.0% | 1.44% | -12.9% | |
FIVN | FIVE9 INC | $39,059,000 | +26.4% | 894,000 | 0.0% | 1.43% | +11.8% | |
NEP | Sell | NEXTERA ENERGY PARTNERS LP | $38,776,000 | +3.1% | 799,500 | -0.8% | 1.42% | -8.8% |
KAR | KAR AUCTION SVCS INC | $36,411,000 | +8.9% | 610,000 | 0.0% | 1.34% | -3.6% | |
LRCX | LAM RESEARCH CORP | $34,436,000 | -12.2% | 227,000 | 0.0% | 1.26% | -22.3% | |
STLD | STEEL DYNAMICS INC | $34,073,000 | -1.7% | 754,000 | 0.0% | 1.25% | -13.0% | |
CCI | CROWN CASTLE INTL CORP NEW | $33,956,000 | +3.3% | 305,000 | 0.0% | 1.25% | -8.6% | |
COLL | COLLEGIUM PHARMACEUTICAL INC | $32,540,000 | -38.2% | 2,207,610 | 0.0% | 1.20% | -45.3% | |
ASML | ASML HOLDING N V | $32,339,000 | -5.0% | 172,000 | 0.0% | 1.19% | -15.9% | |
MGA | Sell | MAGNA INTL INC | $32,238,000 | -9.8% | 613,700 | -0.1% | 1.18% | -20.1% |
STKL | SUNOPTA INC | $31,609,000 | -12.5% | 4,300,540 | 0.0% | 1.16% | -22.5% | |
WBC | WABCO HLDGS INC | $30,145,000 | +0.8% | 255,600 | 0.0% | 1.11% | -10.8% | |
INST | Sell | INSTRUCTURE INC | $28,525,000 | -28.8% | 805,796 | -14.5% | 1.05% | -37.0% |
LEA | LEAR CORP | $26,680,000 | -22.0% | 184,000 | 0.0% | 0.98% | -30.9% | |
MGTA | Buy | MAGENTA THERAPEUTICS INC | $26,256,000 | -11.0% | 2,238,089 | +0.0% | 0.96% | -21.3% |
ANAB | Buy | ANAPTYSBIO INC | $26,167,000 | +411.6% | 262,275 | +264.3% | 0.96% | +353.3% |
LII | LENNOX INTL INC | $25,771,000 | +9.1% | 118,000 | 0.0% | 0.95% | -3.5% | |
ROP | ROPER TECHNOLOGIES INC | $25,770,000 | +7.4% | 87,000 | 0.0% | 0.95% | -5.0% | |
ARGX | Buy | ARGENX SEsponsored adr | $25,406,000 | +206.6% | 335,000 | +235.0% | 0.93% | +171.2% |
ECYT | Buy | ENDOCYTE INC | $23,337,000 | +383.2% | 1,314,000 | +275.4% | 0.86% | +328.5% |
APTV | Buy | APTIV PLC | $22,619,000 | -4.8% | 269,600 | +4.0% | 0.83% | -15.7% |
BPMC | Buy | BLUEPRINT MEDICINES CORP | $22,013,000 | +131.2% | 282,000 | +88.0% | 0.81% | +104.6% |
PEGI | Buy | PATTERN ENERGY GROUP INCcl a | $21,171,000 | +6.2% | 1,065,500 | +0.2% | 0.78% | -6.0% |
IPHI | INPHI CORP | $21,079,000 | +16.5% | 555,000 | 0.0% | 0.77% | +3.1% | |
QURE | Sell | UNIQURE NV | $20,731,000 | -27.3% | 569,700 | -24.4% | 0.76% | -35.7% |
VCYT | VERACYTE INC | $20,375,000 | +2.2% | 2,133,500 | 0.0% | 0.75% | -9.6% | |
KALV | KALVISTA PHARMACEUTICALS INC | $19,899,000 | +172.3% | 900,000 | 0.0% | 0.73% | +141.3% | |
MYOK | MYOKARDIA INC | $19,690,000 | +31.3% | 302,000 | 0.0% | 0.72% | +16.2% | |
NBIX | NEUROCRINE BIOSCIENCES INC | $19,180,000 | +25.2% | 156,000 | 0.0% | 0.70% | +10.7% | |
GTTN | GTT COMMUNICATIONS INC | $19,139,000 | -3.6% | 441,000 | 0.0% | 0.70% | -14.7% | |
MNTA | Buy | MOMENTA PHARMACEUTICALS INC | $19,068,000 | +110.0% | 725,000 | +63.3% | 0.70% | +85.7% |
SLDB | SOLID BIOSCIENCES INC | $18,872,000 | +32.4% | 400,000 | 0.0% | 0.69% | +17.3% | |
STRO | New | SUTRO BIOPHARMA INC | $18,134,000 | – | 1,244,895 | +100.0% | 0.67% | – |
STML | STEMLINE THERAPEUTICS INC | $18,034,000 | +3.4% | 1,086,400 | 0.0% | 0.66% | -8.6% | |
AY | Buy | ATLANTICA YIELD PLC | $17,822,000 | +2.2% | 866,000 | +0.2% | 0.66% | -9.5% |
MTD | METTLER TOLEDO INTERNATIONAL | $17,660,000 | +5.2% | 29,000 | 0.0% | 0.65% | -6.8% | |
ANET | ARISTA NETWORKS INC | $17,547,000 | +3.3% | 66,000 | 0.0% | 0.64% | -8.7% | |
SNA | Sell | SNAP ON INC | $16,891,000 | +11.2% | 92,000 | -2.6% | 0.62% | -1.6% |
PFPT | PROOFPOINT INC | $16,800,000 | -7.8% | 158,000 | 0.0% | 0.62% | -18.4% | |
HASI | Buy | HANNON ARMSTRONG SUST INFR C | $16,145,000 | +10.6% | 752,000 | +1.8% | 0.59% | -2.1% |
PAYC | PAYCOM SOFTWARE INC | $14,919,000 | +57.2% | 96,000 | 0.0% | 0.55% | +39.1% | |
IMMU | IMMUNOMEDICS INC | $14,560,000 | -12.0% | 699,000 | 0.0% | 0.54% | -22.1% | |
CRUS | CIRRUS LOGIC INC | $14,282,000 | +0.7% | 370,000 | 0.0% | 0.52% | -10.9% | |
VKTX | New | VIKING THERAPEUTICS INC | $13,762,000 | – | 790,000 | +100.0% | 0.50% | – |
VYGR | VOYAGER THERAPEUTICS INC | $13,309,000 | -3.2% | 703,425 | 0.0% | 0.49% | -14.2% | |
BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $12,800,000 | +81.2% | 132,000 | +76.0% | 0.47% | +60.4% |
VMC | VULCAN MATLS CO | $12,232,000 | -13.8% | 110,000 | 0.0% | 0.45% | -23.8% | |
SGEN | Sell | SEATTLE GENETICS INC | $11,722,000 | -68.3% | 152,000 | -72.7% | 0.43% | -72.0% |
PTCT | Buy | PTC THERAPEUTICS INC | $11,468,000 | +398.6% | 244,000 | +257.8% | 0.42% | +343.2% |
BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $11,040,000 | +10.0% | 294,000 | +15.7% | 0.40% | -2.9% |
GWPH | GW PHARMACEUTICALS PLCads | $10,969,000 | +23.8% | 63,500 | 0.0% | 0.40% | +9.5% | |
BOLD | AUDENTES THERAPEUTICS INC | $10,887,000 | +3.6% | 275,000 | 0.0% | 0.40% | -8.3% | |
DOOR | MASONITE INTL CORP NEW | $10,897,000 | -10.8% | 170,000 | 0.0% | 0.40% | -21.1% | |
CELG | Sell | CELGENE CORP | $10,739,000 | -62.5% | 120,000 | -66.8% | 0.39% | -66.9% |
EXAS | EXACT SCIENCES CORP | $10,339,000 | +32.0% | 131,000 | 0.0% | 0.38% | +16.9% | |
RCKT | ROCKET PHARMACEUTICALS INC | $9,715,000 | +25.4% | 394,585 | 0.0% | 0.36% | +11.2% | |
IFRX | INFLARX NV | $9,438,000 | +6.4% | 275,000 | 0.0% | 0.35% | -5.7% | |
REGN | REGENERON PHARMACEUTICALS | $9,293,000 | +17.1% | 23,000 | 0.0% | 0.34% | +3.6% | |
XNCR | XENCOR INC | $8,885,000 | +5.3% | 228,000 | 0.0% | 0.33% | -6.9% | |
GBT | New | GLOBAL BLOOD THERAPEUTICS IN | $8,740,000 | – | 230,000 | +100.0% | 0.32% | – |
WVE | Sell | WAVE LIFE SCIENCES LTD | $8,520,000 | -31.8% | 170,400 | -47.8% | 0.31% | -39.6% |
FOLD | New | AMICUS THERAPEUTICS INC | $8,463,000 | – | 700,000 | +100.0% | 0.31% | – |
KNSA | Buy | KINIKSA PHARMACEUTICALS LTD | $8,135,000 | +58.2% | 319,000 | +7.6% | 0.30% | +40.4% |
ETTX | New | ENTASIS THERAPEUTICS HLDGS I | $8,140,000 | – | 772,556 | +100.0% | 0.30% | – |
BCRX | New | BIOCRYST PHARMACEUTICALS | $7,989,000 | – | 1,047,000 | +100.0% | 0.29% | – |
INCY | INCYTE CORP | $7,944,000 | +3.1% | 115,000 | 0.0% | 0.29% | -8.8% | |
XLRN | Sell | ACCELERON PHARMA INC | $7,377,000 | -71.3% | 128,900 | -75.7% | 0.27% | -74.6% |
UROV | New | UROVANT SCIENCES LTD | $7,138,000 | – | 594,816 | +100.0% | 0.26% | – |
MDGL | Sell | MADRIGAL PHARMACEUTICALS INC | $7,066,000 | -45.1% | 33,000 | -28.3% | 0.26% | -51.5% |
RARX | RA PHARMACEUTICALS INC | $7,019,000 | +81.8% | 388,000 | 0.0% | 0.26% | +61.2% | |
CERN | CERNER CORP | $6,969,000 | +7.7% | 108,200 | 0.0% | 0.26% | -4.5% | |
EXR | EXTRA SPACE STORAGE INC | $6,931,000 | -13.2% | 80,000 | 0.0% | 0.26% | -23.0% | |
RARE | ULTRAGENYX PHARMACEUTICAL IN | $6,672,000 | -0.7% | 87,400 | 0.0% | 0.24% | -12.2% | |
SUPN | SUPERNUS PHARMACEUTICALS INC | $6,546,000 | -15.9% | 130,000 | 0.0% | 0.24% | -25.7% | |
RGEN | REPLIGEN CORP | $6,101,000 | +17.9% | 110,000 | 0.0% | 0.22% | +4.2% | |
FENC | FENNEC PHARMACEUTICALS INC | $6,078,000 | -21.5% | 741,175 | 0.0% | 0.22% | -30.5% | |
AGIO | Sell | AGIOS PHARMACEUTICALS INC | $5,784,000 | -61.4% | 75,000 | -57.9% | 0.21% | -65.9% |
ALNY | ALNYLAM PHARMACEUTICALS INC | $5,426,000 | -11.1% | 62,000 | 0.0% | 0.20% | -21.3% | |
SNSS | SUNESIS PHARMACEUTICALS INC | $4,531,000 | -5.7% | 2,265,455 | 0.0% | 0.17% | -16.6% | |
GLPG | GALAPAGOS NVspon adr | $4,497,000 | +22.0% | 40,000 | 0.0% | 0.16% | +7.8% | |
VBIV | VBI VACCINES INC | $4,477,000 | -12.0% | 1,850,000 | 0.0% | 0.16% | -22.3% | |
XENE | New | XENON PHARMACEUTICALS INC | $4,158,000 | – | 315,000 | +100.0% | 0.15% | – |
DERM | DERMIRA INC | $3,641,000 | +18.5% | 334,000 | 0.0% | 0.13% | +4.7% | |
IRWD | IRONWOOD PHARMACEUTICALS INC | $3,544,000 | -3.5% | 192,000 | 0.0% | 0.13% | -14.5% | |
CRNX | New | CRINETICS PHARMACEUTICALS IN | $3,530,000 | – | 123,225 | +100.0% | 0.13% | – |
MGNX | MACROGENICS INC | $3,152,000 | +3.8% | 147,000 | 0.0% | 0.12% | -7.9% | |
IOVA | IOVANCE BIOTHERAPEUTICS INC | $3,150,000 | -12.1% | 280,000 | 0.0% | 0.12% | -22.1% | |
BEP | Buy | BROOKFIELD RENEWABLE PARTNERpartnership unit | $3,115,000 | +1.6% | 103,000 | +1.0% | 0.11% | -10.2% |
ABB | Buy | ABB LTDsponsored adr | $2,918,000 | +21.3% | 123,500 | +11.8% | 0.11% | +7.0% |
CBIO | CATALYST BIOSCIENCES INC | $2,652,000 | -7.6% | 246,000 | 0.0% | 0.10% | -18.5% | |
TSM | TAIWAN SEMICONDUCTOR MFG LTDsponsored adr | $2,628,000 | +20.8% | 59,500 | 0.0% | 0.10% | +7.8% | |
FHB | Buy | FIRST HAWAIIAN INC | $2,526,000 | -5.9% | 93,000 | +0.5% | 0.09% | -16.2% |
HMC | Buy | HONDA MOTOR LTD | $2,391,000 | +7.5% | 79,500 | +4.6% | 0.09% | -4.3% |
JCI | Sell | JOHNSON CTLS INTL PLC | $2,170,000 | -3.9% | 62,000 | -8.1% | 0.08% | -14.9% |
ETN | Sell | EATON CORP PLC | $2,090,000 | +14.1% | 24,100 | -1.6% | 0.08% | +1.3% |
TERP | Buy | TERRAFORM PWR INC | $2,079,000 | +43.9% | 180,000 | +45.7% | 0.08% | +26.7% |
BG | Buy | BUNGE LIMITED | $1,958,000 | +2.1% | 28,500 | +3.6% | 0.07% | -10.0% |
BDN | BRANDYWINE RLTY TRsh ben int new | $1,800,000 | -6.9% | 114,500 | 0.0% | 0.07% | -17.5% | |
SYRS | SYROS PHARMACEUTICALS INC | $1,787,000 | +16.6% | 150,000 | 0.0% | 0.07% | +3.1% | |
MLHR | Buy | MILLER HERMAN INC | $1,728,000 | +15.8% | 45,000 | +2.3% | 0.06% | +1.6% |
SEP | Sell | SPECTRA ENERGY PARTNERS LP | $1,678,000 | -21.0% | 47,000 | -21.7% | 0.06% | -29.5% |
DLPH | DELPHI TECHNOLOGIES PLC | $1,652,000 | -31.0% | 52,666 | 0.0% | 0.06% | -38.4% | |
GPMT | Buy | GRANITE PT MTG TR INC | $1,668,000 | +10.8% | 86,500 | +5.5% | 0.06% | -1.6% |
ALLK | New | ALLAKOS INC | $1,575,000 | – | 35,000 | +100.0% | 0.06% | – |
EPIX | Sell | ESSA PHARMA INC | $1,494,000 | -18.0% | 481,970 | -0.0% | 0.06% | -27.6% |
CCIPRA | CROWN CASTLE INTL CORP NEW6.875% con pfd a | $1,472,000 | +2.0% | 1,355 | 0.0% | 0.05% | -10.0% | |
Buy | HANNON ARMSTRONG SUST INFR Cnote 4.125% 9/0 | $1,361,000 | +5.7% | 1,394,000 | +4.3% | 0.05% | -5.7% | |
APU | Buy | AMERIGAS PARTNERS L Punit l p int | $1,304,000 | -3.5% | 33,000 | +3.1% | 0.05% | -14.3% |
CVA | COVANTA HLDG CORP | $1,276,000 | -1.5% | 78,500 | 0.0% | 0.05% | -13.0% | |
ARE | Buy | ALEXANDRIA REAL ESTATE EQ IN | $1,258,000 | +4.9% | 10,000 | +5.3% | 0.05% | -8.0% |
VTR | VENTAS INC | $1,169,000 | -4.5% | 21,500 | 0.0% | 0.04% | -15.7% | |
CWEN | New | CLEARWAY ENERGY INCcl c | $1,174,000 | – | 61,000 | +100.0% | 0.04% | – |
ERIC | ERICSSONadr b sek 10 | $1,078,000 | +14.7% | 122,500 | 0.0% | 0.04% | +2.6% | |
WELL | Sell | WELLTOWER INC | $1,036,000 | -6.1% | 16,100 | -8.5% | 0.04% | -17.4% |
PLD | PROLOGIS INC | $1,017,000 | +3.2% | 15,000 | 0.0% | 0.04% | -9.8% | |
CIG | Buy | COMPANHIA ENERGETICA DE MINAsp adr n-v pfd | $881,000 | +10.1% | 515,000 | +18.4% | 0.03% | -3.0% |
IR | INGERSOLL-RAND PLC | $757,000 | +14.0% | 7,400 | 0.0% | 0.03% | 0.0% | |
LPT | Sell | LIBERTY PPTY TRsh ben int | $655,000 | -15.6% | 15,500 | -11.4% | 0.02% | -25.0% |
LXP | LEXINGTON REALTY TRUST | $664,000 | -4.9% | 80,000 | 0.0% | 0.02% | -17.2% | |
Buy | DERMIRA INCnote 3.000% 5/1 | $584,000 | +41.4% | 700,000 | +40.0% | 0.02% | +23.5% | |
PSA | PUBLIC STORAGE | $403,000 | -11.2% | 2,000 | 0.0% | 0.02% | -21.1% | |
ABBV | Sell | ABBVIE INC | $378,000 | -99.1% | 4,000 | -99.1% | 0.01% | -99.2% |
ACORDA THERAPEUTICS INCnote 1.750% 6/1 | $340,000 | -12.6% | 400,000 | 0.0% | 0.01% | -25.0% | ||
HERCULES CAPITAL INCdbcv 4.375% 2/0 | $194,000 | -3.0% | 200,000 | 0.0% | 0.01% | -12.5% | ||
VICL | Exit | VICAL INC | $0 | – | -300,000 | -100.0% | -0.01% | – |
EIGR | Exit | EIGER BIOPHARMACEUTICALS INC | $0 | – | -36,000 | -100.0% | -0.02% | – |
AYI | Exit | ACUITY BRANDS INC | $0 | – | -6,850 | -100.0% | -0.03% | – |
NYLD | Exit | NRG YIELD INCcl c | $0 | – | -61,000 | -100.0% | -0.04% | – |
TSRO | Exit | TESARO INC | $0 | – | -26,000 | -100.0% | -0.05% | – |
ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -113,600 | -100.0% | -0.07% | – |
DBVT | Exit | DBV TECHNOLOGIES S Asponsored adr | $0 | – | -170,000 | -100.0% | -0.14% | – |
EIDX | Exit | EIDOS THERAPEUTICS INC | $0 | – | -162,000 | -100.0% | -0.14% | – |
JELD | Exit | JELD-WEN HLDG INC | $0 | – | -700,000 | -100.0% | -0.83% | – |
ARW | Exit | ARROW ELECTRS INC | $0 | – | -295,000 | -100.0% | -0.92% | – |
ELLI | Exit | ELLIE MAE INC | $0 | – | -242,000 | -100.0% | -1.04% | – |
IDTI | Exit | INTEGRATED DEVICE TECHNOLOGY | $0 | – | -826,000 | -100.0% | -1.09% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-14
About Eventide Asset Management
Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.
The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.
The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.
Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.
Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
LOWES COS INC | 40 | Q3 2023 | 3.2% |
PALO ALTO NETWORKS INC | 40 | Q3 2023 | 3.6% |
ASML HOLDINGS NV | 40 | Q3 2023 | 1.9% |
NEUROCRINE BIOSCIENCES INC | 40 | Q3 2023 | 1.1% |
REPLIGEN CORP | 40 | Q3 2023 | 0.5% |
VERACYTE INC | 38 | Q3 2023 | 1.5% |
LAM RESEARCH CORP | 35 | Q3 2023 | 3.4% |
XPO LOGISTICS INC | 34 | Q1 2023 | 3.8% |
COLLEGIUM PHARMACEUTICAL INC | 34 | Q3 2023 | 2.6% |
MAGNA INTL INC | 33 | Q4 2021 | 2.5% |
View Eventide Asset Management's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Cogent Biosciences, Inc. | February 14, 2023 | 2,589,778 | 3.7% |
ESSA Pharma Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Freeline Therapeutics Holdings plc | February 14, 2023 | 5,920,765 | 9.1% |
KnowBe4, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Praxis Precision Medicines, Inc. | February 14, 2023 | 3,518,062 | 7.5% |
Prometheus Biosciences, Inc. | February 14, 2023 | 1,032,938 | 2.2% |
SUTRO BIOPHARMA, INC.Sold out | February 14, 2023 | 0 | 0.0% |
Vital Farms, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Zymeworks Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Entasis Therapeutics Holdings Inc. | February 14, 2022 | 590,602 | 1.2% |
View Eventide Asset Management's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR/A | 2024-02-20 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
View Eventide Asset Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.